MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Cash Flow Overview

Unit: Dollar
Positive Cash Flow Breakdown
    • Stock-based compensation
    • Prepaid expenses
    • Non-cash lease expense
Negative Cash Flow Breakdown
    • Accounts payable and other curre...
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-613,933
-686,425
-1,295,365
-712,184
Stock-based compensation
33,000
-
0
0
Non-cash lease expense
2
159
237
238
Prepaid expense and other assets
-
-
-16,288
-
Prepaid expenses
-13,927
13,835
-
-4,597
Accounts payable and other current liabilities
-208,216
-384,781
678,042
-53,896
Net cash flows from operating activities
-775,220
-1,084,515
-601,165
-761,245
Net change in cash and cash equivalents
-775,220
-1,084,515
-601,165
-761,245
Cash and cash equivalents at beginning of period
1,290,978
2,375,493
2,976,658
5,606,863
Cash and cash equivalents at end of period
515,758
1,290,978
2,375,493
2,976,658
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

INTI Cash Flow Sankey DiagramSankey diagram visualizing INTI cash flow for the periodNet change in cashand cash...-$775,220 (58.52%↑ Y/Y)Stock-based compensation$33,000 (41.12%↑ Y/Y)Prepaid expenses-$13,927 (-429.24%↓ Y/Y)Non-cash lease expense$2 (-99.37%↓ Y/Y)Net cash flows fromoperating activities-$775,220 (58.52%↑ Y/Y)Canceled cashflow$46,929 Net loss-$613,933 (52.51%↑ Y/Y)Accounts payable andother current...-$208,216 (65.04%↑ Y/Y)

Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics, Inc. (INTI)